Get startedLog in
    Picture of Lees Pharmaceutical Holdings logo

    950 — Lees Pharmaceutical Holdings Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Lees Pharmaceutical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line1341,96967.930.898.1
    Depreciation
    Amortisation
    Non-Cash Items107-1,90271.628.170.5
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-149-3.45-8.36-98.3-74.4
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities219211284110242
    Capital Expenditures-358-371-214-160-208
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-1660.443-42.214.517.3
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-524-370-256-145-190
    Financing Cash Flow Items31.20———
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-9.861-12913.4-1.96
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-318-97.7-88.2-21.849.3